First 100 speakers revealed for The Longevity Show

Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision.

Please get in touch if you are interested:

Scientists, founders, clinicians and consumer health voices will gather in London as the event unveils the breadth of its inaugural program.

The Longevity Show has just dropped its first 100 speakers for its June debut at London’s Tobacco Dock – a move that signals a clear break from the standard industry ‘echo chamber.’ Rather than another closed-door conference, this is a calculated attempt to bridge the gap between hard geroscience and the mainstream public. By running a high-level business conference alongside a consumer-facing program, the event is reflecting a reality we can no longer ignore: longevity is moving out of the lab and into the center of the cultural and economic zeitgeist.

The announcement marks a shift in approach from the event’s earlier speaker releases. Rather than introducing names incrementally, organizers have chosen to unveil a substantial cohort at once, offering an early view of the scope and ambition of the program as early-bird ticket sales continue through to the end of March.

Longevity.Technology: The decision to unveil the first 100 speakers in one sweep is more than a programming update – it is a useful snapshot of how far the longevity field has evolved. This 100-speaker drop is more than a programming update; it’s a snapshot of an industry that has finally outgrown its niche. We are moving past the era of biogerontologists talking to themselves and into a multidisciplinary ecosystem that pulls in venture capital, clinical medicine and, crucially, mainstream culture. The sheer diversity of this lineup – spanning from Steve Horvath to Joe Wicks – highlights a central reality: you cannot scale healthspan in a silo. If the science doesn’t translate into public behavior, it stays in the lab; this program is an attempt to build the bridge between the two. Scientific discovery must translate into clinical practice, preventive strategies and everyday behavior change – and that requires dialogue between those advancing the science and those capable of bringing its insights to millions. At the same time, the scale of the line-up reflects the growing momentum of what is now widely termed the longevity economy; as populations age and the imperative to extend healthy years becomes both a medical and economic priority, the once-fringe pursuit of longevity science is steadily moving into the mainstream – and with it, a new generation of collaborations, conversations and, perhaps most importantly, public engagement.

A program spanning science, business and public health

The Longevity Show is structured around two complementary tracks. The business conference will focus on the rapidly expanding longevity sector – from biotech innovation and diagnostics to investment and policy – while the public program is designed to engage a broader audience interested in improving healthspan through evidence-based lifestyle and preventive approaches.

The first wave of announced speakers illustrates that dual structure. On the business and industry side, confirmed participants include Dr Helen O’Neill, epigenetic aging pioneer Steve Horvath, physician and digital health entrepreneur Dr Poonam Desai and longevity investment leader Joanna Bensz. They are joined by Sebnem Avsar Tuna, Andrea Ghirardi, Iain De Havilland, Dr Ana Baroni, Dr Aamer Khan and Tina Woods – figures spanning biotechnology, clinical practice, investment and longevity policy.

Science meets everyday health

Alongside the industry heavyweights sits a group of high-leverage consumer voices, a move that reflects the show’s focus on translating longevity science into actual daily behavior. Broadcasters like Fearne Cotton and Davina McCall – who has single-handedly shifted the mainstream conversation on menopause – are joined by fitness powerhouses Joe Wicks, Grace Beverley and Leanne Hainsby. This isn’t just about adding ‘lifestyle’ flair; it’s a strategic decision to place clinicians like Dr Rangan Chatterjee next to communicators who can actually scale healthspan insights to a mass audience.

The lineup bridges the gap from skincare and wellness pioneer Liz Earle to tech entrepreneur Naveen Jain, while pulling in fitness and performance experts like Jacqueline Hooton and Jamie Bigg. For a field that lives or dies by prevention, these partnerships are no longer optional. If we want longevity to be more than an elite pursuit, we need the voices that can turn metabolic theory into a morning routine.

A gathering for a growing longevity economy

Interest in longevity has accelerated in recent years, driven by advances in geroscience, AI-enabled drug discovery, biomarker development and a growing recognition that aging populations present both a challenge and an opportunity for healthcare systems worldwide. Conferences and industry gatherings have multiplied accordingly; yet many remain either highly technical scientific meetings or consumer wellness events.

The Longevity Show’s hybrid format suggests an attempt to bridge that divide. Researchers exploring the biology of aging, founders building longevity companies, investors shaping the sector’s capital flows and practitioners working directly with patients will share a common stage – while the public program offers a parallel space for individuals seeking practical insight into healthspan.

The conversation widens

The longevity field is still young, still evolving and still defining its boundaries. Yet moments like this – when researchers, physicians, founders and public voices gather under one roof – offer a glimpse of what the next phase might look like. A broader conversation. A more visible one. And perhaps, if the science continues to translate successfully, a more practical one too.

The Longevity Show opens its doors on 26–27 June 2026 at Tobacco Dock, London. Early bird tickets for all tiers are now available at www.longevityshow.com until 31 March 2026.

Eleanor Garth

Editor

Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.

With a keen interest in all things geroscience, Eleanor covers the biological mechanisms of aging, highlighting how interventions – from nutritional strategies to advanced therapeutics – can influence the aging process at a cellular level. She also investigates the broader implications of aging research, including the integration of longevity science into healthcare strategy and the expanding wellness economy. Her work (hopefully) provides insights into how these developments are shaping the emerging landscape of healthspan optimization and age-related innovation.

Sign up for our daily newsletter to get our biggest longevity stories, handpicked for you each day.

The latest longevity science, investment, innovation and insight, delivered every morning.

Unlock Longevity Biotech Report for FREE